Dr. Shiv Kumar Sarin, DM
Institute of Liver & Biliary Sciences
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Dr. Shiv Kumar Sarin, DM as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 08:33 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT07131306 · National Collaborative Centre for Hepatic Regenerative Medicine (NC-CHRM): Evaluating Mesenchymal Stem Cell Therapy in Non-viral Acute on Chronic Liver Failure (ACLF) Patient- Phase-II TrialInstitute of Liver and Biliary Sciences, India · not yet recruiting · Acute-On-Chronic Liver Failure · principal investigator
- N/ANCT07131280 · National Collaborative Centre for Hepatic Regenerative Medicine (NC-CHRM): Single vs Repeated Cycle of Granulocyte Colony-Stimulating Factor (GCSF) & Darbepoetin in Early Decompensated CirrhosisInstitute of Liver and Biliary Sciences, India · not yet recruiting · Decompensated Cirrhosis · principal investigator
- Ph1NCT07131540 · National Collaborative Centre for Hepatic Regenerative Medicine (NC-CHRM): Phase I Study on Safety and Efficacy of Mesenchymal Stem-Cell (MSC) Therapy in Non-Viral Acute-on-Chronic Liver Failure (ACLF)Institute of Liver and Biliary Sciences, India · not yet recruiting · Acute-On-Chronic Liver Failure · principal investigator
- Ph3NCT07075315 · National Collaborative Centre for Hepatic Regenerative Medicine (NC-CHRM): Evaluating Mesenchymal Stem-Cell (MSC) Therapy in Non-viral Acute on Chronic Liver Failure (ACLF) Patients - Phase-III TrialInstitute of Liver and Biliary Sciences, India · not yet recruiting · Acute-On-Chronic Liver Failure · principal investigator
- N/ANCT04352491 · An Online Survey to Understand Feelings Related to COVID-19 Among ILBS Patients With Liver DiseaseInstitute of Liver and Biliary Sciences, India · completed · COVID 19
- N/ANCT04089878 · "To Study the Impact of Balloon-occluded Retrograde Transvenous Obliteration (BRTO)/Plug Assisted Retrograde Transvenous Obliteration (PARTO) Mediated Portal Flow Modulation in Reduction of Ammonia and Improvement in Organ Volume and Functionality in Patients of Cirrhosis With LR ShuntInstitute of Liver and Biliary Sciences, India · unknown · Liver Cirrhoses
Grants
NIH projects from RePORTER, fetched 2026-11-12 08:33 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 46 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name.